Company intelligence / Profile preview

Alkemi

Ownership: Private
Development stage: Other

Overview

Alkemi is a leading consulting firm specializing in market access and evidence strategy for rare disease therapies and innovative health technologies. The company partners with pharmaceutical, biotech, and medtech leaders to reduce launch uncertainty by providing step-by-step "Breakthrough Blueprints" that facilitate access to breakthrough treatments. Their expertise spans value assessments, evidence planning, health economics outcomes research (HEOR), and value communications throughout the product lifecycle for US and global markets.

Therapeutic areas: OtherRare Diseases
Industry: Consulting

Partnerships

Confidential client list; works with major pharma/biotech/device firms

Beyond the preview

Go deeper on Alkemi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alkemi.

Explore the full profile